17
Aug
2026
17
Aug
2026
The male aesthetics market is growing, and clinics are increasingly looking at how to make aesthetic treatments more relevant and appealing to male patients.
Teoxane has now introduced babyGLOW™ for HIM, a new male-adapted eight-point injection protocol designed to improve skin quality, hydration and overall appearance without altering facial features.
For UK and Irish aesthetic clinics, the launch is an interesting development. It reflects a wider shift towards subtle, natural-looking treatments that aim to make patients look refreshed rather than visibly treated.
Men are becoming an increasingly important part of the aesthetics market. According to data cited by Teoxane, male patients represented nearly 14% of aesthetic procedure patients worldwide in 2024, with this proportion expected to increase to more than 20% by 2034. [1]
Yet there are still barriers that can prevent men from seeking aesthetic treatment. Teoxane highlights concerns around stigma, visible results, downtime and the fear of looking "cosmetically done" as some of the reasons men may hesitate to undergo treatment. [2]
The expectations of male patients are also evolving.
According to Teoxane, today's male patients are looking for treatments that provide immediate but natural-looking results, fit easily into busy lifestyles and help them look refreshed rather than transformed. Professional confidence, a healthier appearance and subtle enhancement are among the drivers behind this growing demand. [2]
For clinics, that creates an opportunity to think differently about how aesthetic treatments are presented to male patients.
babyGLOW™ for HIM is described by Teoxane as a male-adapted evolution of its babyGLOW™ skin quality technique.
The eight-point injection protocol has been developed specifically around male facial anatomy and masculine aesthetic preferences. Teoxane highlights anatomical differences including thicker skin, stronger musculature and different patterns of light reflection across the male face. [5,6]
The treatment uses TEOSYAL® PureSense Redensity 1, which Teoxane describes as a regenerative skin booster combining pure high molecular weight, non-crosslinked hyaluronic acid with a dermo-restructuring complex containing amino acids, antioxidants, minerals and vitamin B6. [8]
The eight strategic injection points are designed to improve skin quality while respecting masculine facial characteristics and the patient's existing facial identity.
According to Teoxane, the treatment can be carried out in under 10 minutes on average, with minimal pain and downtime. The company also highlights immediately visible and natural-looking results, as well as straightforward assessment and mapping for practitioners. [3,4,7]
For men who may be considering aesthetic medicine for the first time, that combination of speed, subtlety and limited downtime could be particularly relevant.
One of the more interesting aspects of babyGLOW™ for HIM is its focus on enhancement rather than transformation.
Teoxane describes the approach as supporting healthier-looking, more energised skin rather than changing the patient's facial features. [7]
That distinction could be important when talking to male patients.
A man who is concerned about looking tired, having dull or dehydrated skin, or simply wanting to look healthier may not necessarily be interested in changing the shape of his face.
He may, however, be interested in looking more refreshed.
For practitioners, skin quality can therefore provide a useful way into the conversation about aesthetic medicine without immediately moving towards more obvious facial enhancement.
Teoxane positions babyGLOW™ for HIM as an accessible first treatment for men exploring aesthetics, with the protocol designed to improve skin quality while maintaining the patient's facial identity. [7]
Teoxane reports strong satisfaction among the male patients treated with the protocol.
The company's reported results include:
These figures are certainly interesting from a clinic perspective, particularly the reported willingness to repeat and recommend the treatment.
However, it is important to put the figures into context. The results are Teoxane's own patient feedback and data on file, with the company stating that the patient data was collected in June 2026. They should therefore not be presented as independent clinical trial results. [3]
Male patients can approach aesthetic medicine differently, and Teoxane suggests that the first treatment experience can be particularly important.
The company identifies looking less tired, feeling more energised and projecting confidence in professional environments among the motivations driving treatment adoption in men. [2]
That makes the concept of a quick skin-quality treatment particularly interesting.
For a patient who has never had an aesthetic treatment before, an approach that promises a refreshed appearance without changing their facial features may feel considerably less daunting than a more transformative procedure.
It may also fit more easily around work and other commitments.
Teoxane reports that 100% of patients in its feedback felt comfortable returning to their daily activities on the same day. [3]
Of course, individual patient suitability and outcomes will depend on clinical assessment, treatment technique and the patient's own circumstances.
Teoxane says babyGLOW™ for HIM can be used as a standalone treatment or incorporated into broader treatment and complementary skincare protocols. [7]
That flexibility could make it relevant to different types of male patient.
For someone looking for an initial introduction to aesthetic medicine, it could provide a standalone skin-quality treatment.
For an existing patient, it could potentially form part of a broader treatment plan focused on maintaining and improving skin quality.
The important point for clinics is that the treatment is positioned around the patient's individual goals rather than a one-size-fits-all approach.
The launch of babyGLOW™ for HIM is part of a wider change in the aesthetics market.
Men are no longer a niche consideration for aesthetic clinics, and the industry is developing more treatments and approaches specifically around their anatomy, expectations and concerns.
For UK and Irish clinics, that raises some interesting questions.
Are your treatment consultations designed with male patients in mind?
Does your website reflect the types of results men are looking for?
Do your treatment descriptions focus on natural-looking outcomes and skin health as well as rejuvenation?
And are you making it clear that aesthetic treatment does not necessarily mean changing the way someone looks?
These considerations may become increasingly important as the male patient market continues to grow.
The opportunity may not be about creating an entirely separate "men's aesthetics" offering. It could simply be about understanding that men may approach the same conversation from a different starting point.
For some patients, the goal may be to look younger.
For others, it may simply be to look less tired, healthier or more refreshed.
That makes skin quality an area worth watching.
Teoxane officially introduced babyGLOW™ for HIM at IMCAS 2026, describing the launch as part of its continued focus on developing tailored aesthetic solutions for different patient profiles. [7]
Whether this particular technique becomes widely adopted remains to be seen, but the direction of travel is clear.
As more men consider aesthetic medicine, treatments that prioritise subtle results, convenience and maintaining facial identity are likely to become increasingly relevant.
For clinics, the bigger opportunity may be to understand what male patients actually want from aesthetic medicine — and to create an experience that makes that first treatment feel straightforward, discreet and worthwhile.
babyGLOW™ for HIM is one example of how the industry is responding to that demand.
References
Important information
TEOXANE states that its products are medical devices for professional use only and that product indications and availability vary from country to country. Practitioners should consult locally approved product information for full details. The company also states that the healthcare professional remains responsible for determining the appropriate injection technique based on their assessment of the patient, their needs and the volume to be injected.
Read it? Loved it? Want to share it?
